Seasonal allergy

17 clinical trials

Quick filters

Clinical trials for Seasonal allergy

17 trials across Europe

See all trials →

Quick filters

17 Clinical trials

Seasonal allergy

Recruiting

Registered drug

Short‑course sublingual ITULAZAX birch pollen extract with Lactobacillus rhamnosus GG for patients with pollen‑associated food allergy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Betula Verrucosa (108)
Sponsor:Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)

Contact Research Centre

Conjunctivitis allergic+3

Recruiting

Investigational

Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
Sponsor:Inmunotek S.L.

Contact Research Centre

Seasonal allergy

Not yet recruiting

Registered drug

Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

Registered drug

Poland

Participants:18–64 years
Substances:Placebo
Sponsor:Probelte Pharma S.L.

Contact Research Centre

Conjunctivitis allergic+3

Not yet recruiting

Registered drug

Efficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma

Registered drug

Poland

Participants:0–17 years · 18–64 years
Substances:Bilastine
Sponsor:Inmunotek S.L.

Contact Research Centre

Seasonal allergy

Not yet recruiting

Investigational

Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Phleum Pratense
Sponsor:Asac Pharmaceutical Inmunology S.A.

Contact Research Centre

Seasonal allergy

Not yet recruiting

Registered drug

Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Placebo
Sponsor:Probelte Pharma S.L.

Contact Research Centre

See all trials →

Seasonal allergy

Clinical trials for Seasonal allergy

Seasonal allergy

Short‑course sublingual ITULAZAX birch pollen extract with Lactobacillus rhamnosus GG for patients with pollen‑associated food allergy

Conjunctivitis allergic+3

Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

Seasonal allergy

Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

Conjunctivitis allergic+3

Efficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma

Seasonal allergy

Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

Seasonal allergy

Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.